ArticleClinical ophthalmology (Auckland, N.Z.)2025
Foveal Avascular Zone Area in Patients with Systemic Lupus Erythematosus Using Optical Coherence Tomography Angiography.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the area of the superficial foveal avascular zone (SFAZ) and deep foveal avascular zone (DFAZ) in patients with systemic lupus erythematosus (SLE) using optical coherence tomography angiography (OCT-A) and to associate the SFAZ and DFAZ areas with medication. Design: A cross-sectional observational study. Patients and Methods: This study included 36 eyes of 36 SLE patients and 33 eyes of 33 healthy controls. SFAZ, DFAZ, and central retinal thickness (CRT) were measured using Spectralis OCT-A. Data on medical history and medications were collected to determine associations with SFAZ and DFAZ areas. Results: SFAZ and DFAZ areas showed no significant association with hydroxychloroquine/chloroquine duration or immunosuppressive therapy (p>0.05). Conclusion: The SFAZ and DFAZ areas in patients with SLE were not significantly larger than those in healthy controls. However, the CRT was significantly thinner.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.